Paliperidona Cinfa (Paliperidone)

Paliperidone, the active ingredient in Paliperidona Cinfa, is a antipsychotic presented as a tablet for oral use. It is used to treat schizophrenia and schizoaffective disorder in adults.

GNH USA supplies Paliperidona Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidone is indicated for disorders that involve dopamine dysregulation, particularly within the schizophrenia spectrum. - Schizophrenia: Reduces psychotic symptoms such as hallucinations and delusions. - Schizoaffective disorder: Improves mood and psychotic symptom control. - Bipolar I disorder (maintenance): Helps maintain stability and prevent relapse. - Autistic spectrum disorder associated with irritability: Reduces aggressive behaviour and temper of the but but but but ...

Paliperidone